gestational trophoblastic disease

Gestational trophoblastic disease (GTD) results from the abnormal proliferation of trophoblastic tissue and encompasses a wide spectrum of diseases, including:

• hydatidiform mole
  • complete mole
  • partial mole
  • coexistent molar pregnancy
• invasive mole ~10%
• choriocarcinoma (gestational choriocarcinoma) ~1%
• placental site trophoblastic tumor (PSTT)
• epithelioid trophoblastic tumor (ETT)

Epidemiology

Women older than 40 years and younger than 20 years may be at higher risk.

Clinical presentation

The presentation is variable:

• uterus larger than pregnancy age
• abnormally high β-hCG
• hyperemesis
• hypertension
• theca-lutein cysts

Pathology

A common characteristic of all gestational trophoblastic disease is an abnormal proliferation of trophoblast, but different components predominate in different tumors.

Classification

• hydatidiform mole
  • complete hydatidiform mole (CHM)
    • commonest (up to 80%) manifestation of GTD
    • 46XX or 46XY: paternal chromosomes only
    • no fetus
    • β-hCG markedly elevated
    • atypia of cells present
    • treatment involves
      • curettage +/- hysterectomy in older women
      • follow-up urinary β-hCG for 6-12 months
    • may progress to
      • invasive mole: ≈15% 
      • choriocarcinoma: ≈5%
  • partial hydatidiform mole (PHM)
    • 69XXX or 69XXY (paternal and maternal chromosomes)
    • may have a fetus or fetal components
    • β-hCG moderately elevated
    • no cellular atypia
• invasive mole
  • distorts uterine zonal structures
  • boundaries between a tumor and myometrium are irregular and indistinct
  • may also invade parametrial tissue and blood vessels
• gestational choriocarcinoma
  • may look identical to hydatidiform mole
  • arises following known molar pregnancy (50%), miscarriage (30%), normal pregnancy (20%)
  • can appear to have less vascularity than an invasive mole
  • higher β-hCG levels even than a complete mole
  • solid component with the visualized invasion
  • tends to invade myometrium through venous plexuses
    • patients often can present with multiple metastases without an easily identified primary, as it can often be small in an otherwise normal placenta
  • metastases can occur in
    • lungs: ~80%
    • vagina: ~30%
    • pelvis: 20% 
    • liver and brain: ~10%
• placental site trophoblastic tumor (PSTT)
  • rare form
  • produces small amounts of β-hCG
• epithelioid trophoblastic tumor (ETT)
  • extremely rare form

Siehe auch:

• Blasenmole
• Chorionkarzinom
• complete hydatidiform mole
• gestational choriocarcinoma
• partial hydatidiform mole
• invasive mole
• epithelioid trophoblastic tumour (ETT)
• placental site trophoblastic tumour
• mesenchymale Dysplasie der Plazenta
• ovarian theca lutein cysts
• placental site trophoblastic tumour (PSTT)

und weiter:

• obstetric curriculum
• cancer
• Ovarialzyste
• complete mole
• junctional zone
• maligne Uterustumoren
• retained products of conception
• hydropic degeneration of the placenta
• early pregnancy
• Abortivei
• fruit inspired signs
• per vaginal bleeding in the exam
• verhaltener Abort
• differential diagnosis for bleeding in pregnancy
• empty gestational sac
• arteriovenöse Malformation des Uterus
• Ovarielles Hyperstimulationssyndrom
• chorioadenoma destruens
• coexistant molar pregnancy
• Chorionkarzinom des Uterus